Appeals Court Clears J&J In Remicade Suit

Law360, New York (July 11, 2007, 12:00 AM EDT) -- A man may not proceed with his suit against Johnson & Johnson Inc. that alleged the company's drug, Remicade, caused the blood-clotting that led to the amputation of part of his leg, an appeals court ruled Monday.

A three-judge panel of the U.S. Court of Appeals for the Seventh Circuit upheld a district court's exclusion of the testimony of Dr. Lee McKinley, who was the physician of the plaintiff, Mickey Ervin. McKinley had sworn that Remicade, an anti-Crohn's Disease pharmaceutical, was very likely a “substantial cause”...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.